Skip to main content

Advertisement

Log in

Telemedicine as patient-centred oncology care: will we embrace or resist disruption?

  • Comment
  • Published:

From Nature Reviews Clinical Oncology

View current issue Sign up to alerts

Telemedicine represents the practical embodiment of patient-centred oncology care, a concept that has become increasingly popular in the past few years. Yet despite the demonstrated benefits of telemedicine, its longitudinal adoption remains limited. Herein we discuss some of the potential challenges that telemedicine faces, as we underutilize this approach relative to its anticipated value.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bradbury, A. et al. Utilizing remote real-time videoconferencing to expand access to cancer genetic services in community practices: a multicenter feasibility study. J. Med. Internet Res. 18, e23 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Lally, K., Kematick, B. S., Gorman, D. & Tulsky, J. Rapid conversion of a palliative care outpatient clinic to telehealth. JCO Oncol. Pract. 17, e62–e67 (2021).

    Article  PubMed  Google Scholar 

  3. Cox, A. et al. Cancer survivors’ experience with telehealth: a systematic review and thematic synthesis. J. Med. Internet Res. 19, e11 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Patel, K. B. et al. Estimated indirect cost savings of using telehealth among nonelderly patients with cancer. JAMA Netw. Open 6, e2250211 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Shaverdian, N. et al. Impact of telemedicine on patient satisfaction and perceptions of care quality in radiation oncology. J. Natl. Compr. Canc. Netw. 19, 1174–1180 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Patel, K. B. et al. Telemedicine adoption in an NCI-designated cancer center during the COVID-19 pandemic: a report on patient experience of care. J. Natl. Compr. Canc. Netw. 21, 496–502.e6 (2023).

    Article  PubMed  Google Scholar 

  7. Gergen Barnett, K. et al. Telehealth’s double-edged sword: bridging or perpetuating health inequities? J. Gen. Intern. Med. 37, 2845–2848 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Tevaarwerk, A. J. et al. Oncologist perspectives on telemedicine for patients with cancer: a National Comprehensive Cancer Network survey. JCO Oncol. Pract. 17, e1318–e1326 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  9. West, H. J., Barzi, A. & Wong, D. Telemedicine in cancer care beyond the COVID-19 pandemic: oncology 2.0? Curr. Oncol Rep. 24, 1843–1850 (2022).

    Article  PubMed  Google Scholar 

  10. West, H. J. For those who participate in multispecialty cancer conferences (a.k.a. tumor boards) that converted from in person to virtual (Zoom, Teams, etc.) in the face of the pandemic, what are you now doing as the “new normal”? #MedTwitter #OncTwitter. twitter, https://twitter.com/JackWestMD/status/1620452640055492614 (accessed 12 May 2023).

Download references

Acknowledgements

E.B. and F.C. receive support from the NIH/NCI (Grant P30 CA008748). E.B. receives support from the NCI MATCHES P50 Grant (P50 CA271357).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Howard Jack West.

Ethics declarations

Competing interests

H.J.W. and F.C. declare no competing interests. E.B. has received consulting fees from Flatiron Health.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

West, H.J., Bange, E. & Chino, F. Telemedicine as patient-centred oncology care: will we embrace or resist disruption?. Nat Rev Clin Oncol 20, 659–660 (2023). https://doi.org/10.1038/s41571-023-00796-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41571-023-00796-5

  • Springer Nature Limited

Navigation